Innovative Cellular Therapeutics has a total of 20 patents globally, out of which 7 have been granted. Of these 20 patents, more than 55% patents are active. China is where Innovative Cellular Therapeutics has filed the maximum number of patents, followed by United States of America and Austria. Parallelly, China seems to be the main focused R&D centre and also is the origin country of Innovative Cellular Therapeutics.
Innovative Cellular Therapeutics was founded in 2009. Innovative Cellular Therapeutics operates in the biotechnology sector, specializing in the development of stem cell, gene editing, and gene therapy technologies.
Do read about some of the most popular patents of Innovative Cellular Therapeutics which have been covered by us in this article and also you can find Innovative Cellular Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Innovative Cellular Therapeutics patent portfolio.
How many patents does Innovative Cellular Therapeutics have?
Innovative Cellular Therapeutics has a total of 20 patents globally. These patents belong to 13 unique patent families. Out of 20 patents, 11 patents are active.
How Many Patents did Innovative Cellular Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Innovative Cellular Therapeutics Applications Filed | Innovative Cellular Therapeutics Patents Granted |
| 2024 | – | 1 |
| 2023 | 2 | – |
| 2022 | – | 2 |
| 2020 | 2 | – |
| 2019 | 4 | – |
| 2017 | 2 | 2 |
| 2015 | – | 1 |
| 2014 | 6 | 1 |
How many Innovative Cellular Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Innovative Cellular Therapeutics File in Different Countries?
Countries in which Innovative Cellular Therapeutics Filed Patents
| Country | Patent |
| China | 11 |
| United States of America | 4 |
| Austria | 1 |
Where are Research Centers of Innovative Cellular Therapeutics Patents Located?
Best Innovative Cellular Therapeutics Patents
WO2014040370A1 is the most popular patent in the Innovative Cellular Therapeutics portfolio. It has received 28 citations so far from companies like Intellia Therapeutics, 64-X Inc.
Below is the list of 10 most cited patents of Innovative Cellular Therapeutics:
| Publication Number | Citation Count |
| WO2014040370A1 | 28 |
| US8748134B2 | 9 |
| CN112111460A | 5 |
| WO2018126369A1 | 3 |
| CN112501125A | 2 |
| CN111019905A | 2 |
| WO2015032340A1 | 2 |
| US9040677B2 | 1 |
| US20180119102A1 | 1 |
List of Innovative Cellular Therapeutics patents
| Publication Number | Title |
| US9567593B2 | Method For Directional Cloning |
| US9040677B2 | Transcription Activator-Like Effector Assembly |
| US8748134B2 | Transcription Activator-Like Effector Assembly |
| CN116535514B | Anti-Guanylate Cyclase C Antibodies And Their Applications In Cancer Treatment |
| CN112638947B | Chimeric Antigen Receptor Cells For The Treatment Of Solid Tumors |
| CN110257338B | Chimeric Cytokine Receptor |
| CN116751300A | Anti-Mesothelin Heavy-Chain Single-Domain Antibody And Application Thereof In Cancer Treatment |
| CN112680419A | Chimeric Antigen Recipient Cell Secretion Therapeutic Agents |
| CN112501125A | Coupled Chimeric Antigen Receptor Cells And Uses Thereof |
| CN113082201A | Methods Of Stimulating T Cell Mediated Immune Response To Antigen-Expressing Cell Populations |
| CN112111460A | Pharmaceutical Composition With Modified Cell Population |
| US20180119102A1 | Modified Cells For Production Of Blood Cells |
| CN111019905A | Chimeric Antigen Receptor (Car) Modified Cells And Use Thereof In Preparation Of Autoimmune Disease Drugs |
| CN106795522A | Method For Directional Cloning |
| CN105518127A | Modified Cells For Production Of Blood Cells |
| WO2018126369A1 | Humanized Anti-Cd19 Antibody And Use Thereof With Chimeric Antigen Receptor |
| WO2016058171A1 | Method For Directional Cloning |
| WO2015032340A1 | Modified Cells For Production Of Blood Cells |
| WO2014040370A1 | Transcription Activator-Like Effector Assembly |
| AT867916T | Arrangement For The Transcription Of An Activator-Like Effector Arrangement |
What are Innovative Cellular Therapeutics key innovation segments?
What Technologies are Covered by Innovative Cellular Therapeutics?
The chart below distributes patents filed by Innovative Cellular Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Innovative Cellular Therapeutics thinks it’s important to protect particular technology inventions.
R&D Focus: How has Innovative Cellular Therapeutics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Innovative Cellular Therapeutics?